Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Recurrent or Progressive Meningiomas
NCT01125046Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jun 2010
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in meningioma, hemangioblastoma, hemangiopericytoma (HPC), vestibular schwannoma (VS), schwannoma, sponsored by Northwestern University. Started Jun 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
meningiomahemangioblastomahemangiopericytoma (HPC)vestibular schwannoma (VS)schwannoma
Beyond the preview
Go deeper on NCT01125046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01125046.